Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

Uncertainty about future care and life impacts were among the top concerns for patients with psoriatic arthritis, but not for ...

Gut transit time varies from one person to the next. Recent estimates suggest it can take somewhere between 12 and 73 hours ...

Medicare’s flexibility for covering other health and medical services via telehealth has been repeatedly extended, but the last of those extensions is effective only through March 31, 2025.

Exposure to TNF inhibitors was linked to a reduced risk for cardiovascular events among patients with AS; the impact of IL-17 inhibitors was less clear.

近日，中南大学湘雅医院骨科/老年骨关节疾病防治教育部重点实验室/国家老年疾病临床医学研究中心雷光华/曾超/魏捷教授团队，在骨关节炎领域顶刊《Annals of the Rheumatic Diseases（风湿病年鉴）》（IF 20.3）以“原创论著 ...

At only 27 years old, Daniela Powers felt like she was dying. What began as unexplained rashes exploded into a debilitating illness in just a four-year span. She visited numerous ...

Obinutuzumab could reshape the treatment of lupus nephritis, a life-threatening complication of lupus that has long lacked ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Optical spectral transmission, a novel noninvasive light-based technology, can effectively differentiate patients with inflammatory arthritis from healthy control individuals, a recent study showed.

Rheumatic and vascular diseases currently affect a large part of the population and can significantly compromise the biomechanics of the lower limb. This condition will be discussed on Saturday, ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a detailed analysis of its phase III REGENCY trial of Gazyva®/Gazyvaro® (obinutuzumab) in people with active lupus nephritis (LN) was published ...